FCBT
VIVO

First Citizens Bank & Trust’s Meridian Bioscience Inc VIVO Stock Holding History

First Citizens Bank & Trust’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-31,640
Closed -$689K – 367
2014
Q1 		$689K Sell
31,640
-12,197
-28% -$280K 0.06% 207
2013
Q4 		$1.16M Buy
43,837
+9,858
+29% +$242K 0.11% 143
2013
Q3 		$803K Buy
33,979
+4,509
+15% +$105K 0.03% 503
2013
Q2 		$634K Buy
+29,470
New +$636K 0.03% 557

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Citizens Bank & Trust's VIVO Position: Q2 2014 in Review

First Citizens Bank & Trust sold out of Meridian Bioscience Inc (VIVO) in Q2 2014, closing a stake of 31,640 shares — an estimated $689K sold.

First Citizens Bank & Trust first reported a position in VIVO in Q2 2013 and held it in 4 quarters. The position peaked at $1.16M in Q4 2013. 161 funds tracked by Wall St. Rank hold VIVO as of Q2 2014.

  • First Citizens Bank & Trust reported no remaining Meridian Bioscience Inc position as of Q2 2014 after selling out during the quarter.
  • First Citizens Bank & Trust sold 31,640 Meridian Bioscience Inc shares in Q2 2014, an estimated $689K.
  • First Citizens Bank & Trust first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 4 quarters.
  • First Citizens Bank & Trust's Meridian Bioscience Inc position peaked at $1.16M in Q4 2013.
  • 161 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2014.

Based on First Citizens Bank & Trust's 13F filing for Q2 2014, filed 5 Aug 2014.